Impact of multimorbidity and polypharmacy on mortality after cancer: a  nationwide registry-based cohort study in Denmark 2005-2017

Conclusion: We found that multimorbidity and polypharmacy was associated with higher mortality in patients diagnosed with cancer types that typically have a favorable prognosis compared with patients without multimorbidity and polypharmacy. Multimorbidity and polypharmacy had less impact on mortality in cancers that typically have a poor prognosis.PMID:37874076 | DOI:10.1080/0284186X.2023.2270145

Source: Acta Oncologica - October 24, 2023 Category: Cancer & Oncology Authors: Mette K Thomsen Katrine B L øppenthin Pernille E Bidstrup Elisabeth W Andersen Susanne Dalton Lone N Petersen Helle Pappot Christiane E Mortensen Mikkel B Christensen Anne Fr ølich Ulrik Lassen Christoffer Johansen Source Type: research